Indian Scientists Discovery can Help Develop New Antibiotics

A potential area where new antibiotics can be developed has been identified by a team of scientists at the Center for Cellular and Molecular Biology (CCMB), Hyderabad.

The identification of “potential drug target” by CCMB scientist Manjula Reddy and her team assumes importance as the drug-resistance in bacteria is increasing worldwide and development of new antibiotics is declining over the years.

Alternative to Antibiotics Found for Deadly Clostridium Difficile Infection
Antioxidant drug ebselen did not kill the bacteria. Rather, it disabled a toxin produced by the pathogen and prevented intestinal damage and inflammation.

"If we have to increase the size of a room, we have to break the walls and put new bricks. Likewise, bacteria are covered with a cell wall. The cell wall is made with something called peptidoglycan. If the cell has to increase in size, it has to break what is there earlier and put new pieces. If it cannot break, cell wall cannot grow," said CCMB Director Ch Mohan Rao.

"She (Manjula Reddy) discovered that there are certain enzymes which break this... If we can target this enzyme and prevent that enzyme from functioning, then cell wall will not be broken. If it will not be broken, it cannot expand. If it cannot expand, it cannot survive," he said.

The study was published in the journal of 'Proceedings of the National Academy of Sciences, USA'.

Antibiotics may Have Caused Neonatal Infection Outbreaks in Greek Hospital
A new study suggests that the recent successive outbreaks of VRE in a Greek neonatal intensive care unit could have been caused by administration of antibiotics.

CCMB scientists have also made a critical discovery in meiosis, said Rao. Meiosis is a special form of cell division that splits genome in two, so that chromosome number is maintained in the embryo after fertilization.

Errors in meiosis result in infertility and birth defects and account for a majority of congenital birth defects.

Better Use of Antibiotics Could Help Fight the Superbugs
Proper use of antibiotics could help fight the infection Clostridium difficile - the superbug.

In plants, meiosis can be bypassed to produce clonal seeds by apomixes (an asexual mode of seed formation), which would be of immense agricultural and economical importance if engineered in crops, said Rao.

Using the model plant Arabidopsis thaliana, the CCMB scientists identified a gene called DUET as the first known regulator of meiotic gene expression in plants, he said.

Training the Pediatricians Encourages Them to Choose Appropriate Antibiotics
Public health experts have called for more selective use of medicines, as disease-causing microbes continue their worrisome trend of developing resistance to commonly used antibiotics.

"The work provides an initial framework that will enable researchers to further unravel the controls of meiotic gene expression in plants, as well as in other systems," said Rao.

The work was published in PLOS Genetics.

CCMB also contributed to a collaborative study with several international institutions on a new genetic link to body fat distribution, which was published in Nature, he said.

The study identified a number of loci (regions in DNA) associated with waist-hip-ratio and waist and hip measures. It will form a foundation for future biological research in the regulation of body fat distribution, he said.

CCMB scientists also contributed to genetic studies on Eimeria (E. tenella) parasites (which cause a disease called coccidiosis in poultry) and their relevance to vaccine development.

"The findings indicate very high level of region-specific diversity. However, polymorphism in EtAMA1 was found to be rather less. This would facilitate vaccine development," said Rao.

The CCMB scientists, led by Rao, also conducted research on a nano-particle based approach for treating fungal keratitis, a major eye problem affecting farmers in India.

The scientists identified specific enzymes released by the pathogen as well the host (humans). They developed a smart polymer base biocompatible nano particles carrying a formulation that is designed to handle the situation effectively.

By combining the specific formulation with the smart delivery mechanisms, they have successfully treated the infection in animal model systems. The approach is being patented and clinical trials will be undertaken subsequently, according to Rao.

The Centre for Cellular and Molecular Biology works under the aegis of Council of Scientific and Industrial Research (CSIR).

Source-PTI